Gelmann EP - Search Results

1

Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.

Branigan GL, Torrandell-Haro G, Soto M, Gelmann EP, Vitali F, Rodgers KE, Brinton RD. Branigan GL, et al. Among authors: gelmann ep. Cancer Med. 2022 Jul;11(13):2687-2698. doi: 10.1002/cam4.4650. Epub 2022 Mar 16. Cancer Med. 2022. PMID: 35293700 Free PMC article.

2

Androgen receptor mutations in prostate cancer.

Gelmann EP. Gelmann EP. Cancer Treat Res. 1996;87:285-302. doi: 10.1007/978-1-4613-1267-3_12. Cancer Treat Res. 1996. PMID: 8886458 Review. No abstract available.

3

Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.

Gelmann EP, Steadman DJ, Ma J, Ahronovitz N, Voeller HJ, Swope S, Abbaszadegan M, Brown KM, Strand K, Hayes RB, Stampfer MJ. Gelmann EP, et al. Cancer Res. 2002 May 1;62(9):2654-9. Cancer Res. 2002. PMID: 11980664

4

Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization.

Zhang Y, Glass A, Bennett N, Oyama KA, Gehan E, Gelmann EP. Zhang Y, et al. Among authors: gelmann ep. Cancer. 2004 Jan 15;100(2):300-7. doi: 10.1002/cncr.11886. Cancer. 2004. PMID: 14716764 Free article.

5

Beta-catenin mutations in human prostate cancer.

Voeller HJ, Truica CI, Gelmann EP. Voeller HJ, et al. Among authors: gelmann ep. Cancer Res. 1998 Jun 15;58(12):2520-3. Cancer Res. 1998. PMID: 9635571

6

Androgen blocks apoptosis of hormone-dependent prostate cancer cells.

Kimura K, Markowski M, Bowen C, Gelmann EP. Kimura K, et al. Among authors: gelmann ep. Cancer Res. 2001 Jul 15;61(14):5611-8. Cancer Res. 2001. PMID: 11454715

7

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Tan SH, et al. Among authors: gelmann ep. Cancer Res. 2008 Jan 1;68(1):236-48. doi: 10.1158/0008-5472.CAN-07-2972. Cancer Res. 2008. PMID: 18172316

8

CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.

Bowen C, Shibata M, Zhang H, Bergren SK, Shen MM, Gelmann EP. Bowen C, et al. Among authors: gelmann ep. Cancer Res. 2020 Nov 1;80(21):4805-4814. doi: 10.1158/0008-5472.CAN-20-1742. Epub 2020 Sep 17. Cancer Res. 2020. PMID: 32943441 Free PMC article.

9

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.

Truica CI, Byers S, Gelmann EP. Truica CI, et al. Among authors: gelmann ep. Cancer Res. 2000 Sep 1;60(17):4709-13. Cancer Res. 2000. PMID: 10987273

10

Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.

Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP, Nevalainen MT. Li H, et al. Among authors: gelmann ep. Clin Cancer Res. 2005 Aug 15;11(16):5863-8. doi: 10.1158/1078-0432.CCR-05-0562. Clin Cancer Res. 2005. PMID: 16115927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page